Company intelligence / Profile preview

Synthetics China

Taixing City / Hongqiao Industrial Park / CMC base in "China Medical City", Jiangsu Province, Chinadnb.com ↗

Ownership: Private
Development stage: Commercial

Overview

Synthetics China is an established supplier to the pharmaceutical industry, specializing in the R&D, production, and supply of intermediates, active pharmaceutical ingredients (APIs), excipients, and cosmetic materials. The company operates with a cGMP-compliant quality management system and offers regulatory services. It does not develop its own clinical pipeline but supports other companies' drug development through manufacturing services.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Synthetics China.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synthetics China.

Explore the full profile